The single-stranded DNA-binding protein, Replication Protein A (RPA), is a heterotrimeric complex with subunits of 70, 32 and 14 kDa involved in DNA metabolism. RPA may be a target for cellular regulation; the 32 kDa subunit (RPA32) is phosphorylated by several cellular kinases including the DNA-dependent protein kinase (DNA-PK). We have purified a mutant hRPA complex lacking amino acids 1-33 of RPA32 (rhRPA•32∆1-33). This mutant bound ssDNA and supported DNA replication; however, rhRPA•32∆1-33 was not phosphorylated under replication conditions or directly by DNA-PK. Proteolytic mapping revealed that all the sites phosphorylated by DNA-PK are contained on residues 1-33 of RPA32. When wild-type RPA was treated with DNA-PK and the mixture added to SV40 replication assays, DNA replication was supported. In contrast, when rhRPA•32∆1-33 was treated with DNA-PK, DNA replication was strongly inhibited. Because untreated rhRPA•32∆1-33 is fully functional, this suggests that the N-terminus of RPA is needed to overcome inhibitory effects of DNA-PK on other components of the DNA replication system. Thus, phosphorylation of RPA may modulate DNA replication indirectly, through interactions with other proteins whose activity is modulated by phosphorylation.
INTRODUCTION
Replication protein A (RPA) is a multi-subunit, single-stranded DNA-binding protein required for multiple processes in DNA metabolism including DNA replication, DNA repair and recombination (1-7). Human RPA (hRPA) consists of 70, 32 and 14 kDa subunits and is a member of a ubiquitous family of eukaryotic single-stranded DNA-binding proteins. Homologous heterotrimeric proteins have been found in all eukaryotic cells examined (8) (9) (10) (11) (12) (13) . RPA binds tightly to single-stranded DNA (ssDNA) (14) and interacts specifically with several proteins involved in DNA replication (15) . Both of these activities are important for RPA function in DNA replication (16, 17) . RPA also interacts with proteins involved in DNA repair (18, 19) , transcription (20, 21) and the cell regulator p53 (20) (21) (22) . The role of these interactions is currently unknown. RPA is also phosphorylated and may be involved in regulating cellular DNA metabolism.
The 32 kDa subunit of RPA is phosphorylated in a cell cycle-dependent manner (23, 24) and in response to DNA damage (25, 26) . Phosphorylation of hRPA occurs at multiple serine residues (27) and occurs efficiently only in the presence of ssDNA (28, 29) . The role of phosphorylation of RPA has been difficult to elucidate because multiple kinases phosphorylate RPA in vitro, including the p34 cdc2 kinase family, the DNA-dependent protein kinase (DNA-PK) and several uncharacterized kinases (24, 27, 28, (30) (31) (32) (33) . However, all the phosphorylation of hRPA detected in cellular extracts is the result of DNA-PK activity, either directly or indirectly (31) . DNA-PK is a serine/threonine kinase activated by dsDNA (34, 35) and implicated to be involved in both recombination and DNA repair (33, (36) (37) (38) . DNA-PK consists of a 350 kDa catalytic subunit (34, 35) that forms a stable complex with the 70 and 80 kDa subunits of the Ku autoantigen (Ku) (39, 40) . Ku has a high affinity for DNA structures containing ends or single to double strand junctions (41) (42) (43) and has been reported to have intrinsic helicase activity (44) . It is postulated that Ku binds the ends of DNA exposed during DNA damage and recombination and helps to localize DNA-PK near appropriate substrates (33) . Recently, several mutant cell lines and mutant mice sensitive to radiation and defective in recombination were shown to be deficient in DNA-PK (36) (37) (38) . In addition, cells from these mice are deficient in RPA kinase activity (45) . Although the physiological substrate(s) of DNA-PK are unknown, many proteins are phosphorylated by DNA-PK in vitro including SV40 large T antigen, p53, and transcription factors such as c-jun and c-fos (33 and references therein).
The physiological role of phosphorylation of RPA is still not known. Several studies have suggested that phosphorylation of RPA is not required for its activity in DNA replication or repair (30, 31, 46, 47) . Extracts immunodepleted of DNA-PK were unable to phosphorylate the 32 kDa subunit of hRPA but did support DNA replication (31). Pan and co-workers found that unphosphorylated and phosphorylated hRPA had equal activity in DNA replication assays carried out in activated extracts and in reconstituted nucleotide excision repair assays (46) . In addition, Figure 1 . Single-stranded DNA-binding activity of rhRPA•32∆1-33. Gel mobility-shift assays were carried out as described previously (14) . Oligonucleotides were labeled with 32 P using polynucleotide kinase (48) . Either no RPA (-) or increasing amounts of rhRPA, rhRPA•32∆1-33 (∆1-33) were incubated with 2 fmol labeled oligo(dT) 30 in a total volume of 15 µl FBB (30 mM HEPES at pH 7.8, 5 mM MgCl 2, 100 mM NaCl, 0.5% inositol and 1 mM DTT). Lanes contain 1, 2.15, 4.64, 10, 21.5, 46.4, 100 fmol of wild-type or mutant complex. After incubation at 25_C for 20 min, the binding reactions were brought to a final concentration of 4% (v/v) glycerol and 0.004% (w/v) bromphenol blue, separated by electrophoresis on a 1% agarose gel in 0.1× TAE buffer (4 mM Tris-acetate, 0.2 mM EDTA, pH 8.5) (Ausubel et al. 1989 ) and analyzed by autoradiography. Binding of hRPA to oligodeoxythymidine was in equilibrium under these conditions (51) . Migration of free (unbound) and bound oligonucleotides are as indicated deletion of the N-terminus of the 32 kDa subunit of hRPA results in a mutant complex that supports replication but is not phosphorylated in vitro (47) . However, it remains possible that phosphorylation of RPA has a role in modulating DNA metabolism in vivo or under certain conditions in vitro. To examine this possibility, we made an N-terminal deletion of RPA32, rhRPA•32∆1-33, that is completely functional in both DNA-binding and SV40 DNA replication reactions but is not phosphorylated by DNA-PK. Using this mutant we show that all phosphorylation of RPA by DNA-PK in vitro occurs on the N-terminal 33 residues of RPA32. In addition we present evidence that the N-terminus of RPA is important for preventing inhibition of DNA replication by DNA-PK. Although the mechanism of this modulation is not yet defined, these studies suggest that it may be accomplished through phosphorylation of multiple proteins and that phosphorylation of RPA is necessary to overcome the inhibitory effect(s) of DNA-PK.
MATERIALS AND METHODS

Reagents
DNA-PK and Ku autoantigen were purified as described previously (34) . [α-32 P]dATP (3000 Ci/mmol) and [γ-32 P]ATP (6000 Ci/mmol) were obtained from Amersham. 1× Tris-acetate-EDTA (TAE) gel buffer contained 40 mM Tris-acetate and 2 mM EDTA, pH 8.5 (48) . Plasmids capable of directing the expression of wild-type RPA (p11d-tRPA) (29) or a mutant RPA complex in which amino acids 1-33 of the RPA32 have been deleted (ptRPA•32∆1-33) (49) have been described previously.
Induction and purification of wild-type and mutant rhRPA p11d-tRPA or ptRPA•32∆1-33 were individually transformed into BL21(DE3), grown and induced (29) . ptRPA•32∆1-33 contains the coding sequence for RPA70, RPA14 and a deletion mutant of RPA32 lacking residues 1-33. Placing the deletion (29) was used in replication studies. Replication assays were carried out as described previously (29) . Cellular components necessary for SV40 replication were supplied as partially purified proteins. Each replication reaction contained CFII (containing DNA polymerases α and δ and RF-C), fraction CFIBC (containing proliferating cell nuclear antigen and protein phosphatase 2A), and purified SV40 T antigen, topoisomerase I and wild-type or mutant RPA. [Characterization of these protein fractions has been described previously (29, 58) .] T antigen (Tag) was added where indicated. The assays were incubated for 2 h and the products analyzed by electrophoresis and autoradiography (29) . (A) Titration of rhRPA or rhRPA•32∆1-33. Indicated amounts of rhRPA or rhRPA•32∆1-33 (1-33) were added to standard replication reactions. (B) Effect of RPA phosphorylation on DNA replication. 300 ng of rhRPA or rhRPA•32∆1-33 were first incubated at 37_C for 30 min in the absence or presence of purified DNA-PK (34) (DNA-PK) as indicated. A synthetic ds-oligonucleotide necessary to obtain maximal DNA-PK activity was added to all lanes containing DNA-PK. After 30 min, the remaining proteins and buffers necessary for replication were added to each reaction. Additional rhRPA (300 ng, RPA) was added as indicted after the initial 30 min incubation. mutant of RPA32 in frame with an initiator methionine resulted in the fusion of three additional residues, methionine-alaninearginine, to the N-terminus of RPA32. Wild-type and mutant rhRPA were purified as previously described (29, 49) .
RESULTS
rhRPA•32∆1-33 has ssDNA binding activity and functions in DNA replication
DNA-PK preferentially phosphorylates serine or threonine residues followed by glutamine (33) . Of the 28 serines within RPA32, only (29, 58) . Lanes 1 and 2 contain indicated protein prior to incubation. Lane 3 contains no added RPA. Proteins were separated on a 15% SDS-polyacrylamide gel and transferred to nitrocellulose. RPA32 was then visualized by probing with monoclonal antibody 71 (29) . Positions of hRPA32 (RPA32) and phosphorylated hRPA32 (RPA32*) are indicated. Phosphorylation of rhRPA mutant complexes by DNA-PK. The indicated protein substrate and DNA-PK were incubated at 37_C for 30 min in DNA-PK reaction buffer (20 mM HEPES pH 7.8, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 10% glycerol, 0.02 % Tween-20, 100 µm ATP, 7.5 mM MgCl 2 and 10 µCi [γ-32 P]ATP). Reactions contained either 1 µg of casein, 0.5 µg of rhRPA or 0.5 µg rhRPA•32∆1-33 and were indicated 0.5 µl of DNA-PK and 0.5 µl Ku autoantigen with 1 µg sheared calf thymus dsDNA. ssM13 (0.1 µg) was included in the reactions as indicated. Reactions were subjected to electrophoresis on an 8-14% SDS-polyacrylamide gel, stained with silver nitrate to visualize proteins (B) and dried onto blotting paper. Incorporation of 32 P into the 32 kDa subunit was detected by autoradiography (C). The location of RPA32 (RPA32) and phosphorylated RPA32 (RPA32*) are indicated. serines 33, 52, 72 and 174 fit this consensus sequence. We began these studies by generating a series of RPA mutants in which individual consensus DNA-PK sites were mutated to alanine. Initially mutants were created at serine 33 or serine 174. We found that these mutant RPA complexes had functional properties identical to wild-type RPA and were phosphorylated by DNA-PK with the same efficiency as wild-type RPA (50) . These studies suggested that phosphorylation of RPA32 by DNA-PK may be occurring at non-consensus sites. Proteolytic studies of the structure of RPA32 indicated the N-terminus is in an extended conformation that may be accessible to cellular kinases (49) . In addition, we had evidence that the N-terminus of RPA was important for its phosphorylation (A. Dutta, unpublished results). Therefore, we examined the biochemical properties of a hRPA complex containing an RPA32 lacking residues 1-33, rhRPA-•32∆1-33 (49) .
Equilibrium binding of hRPA•32∆1-33 to ssDNA was monitored by gel mobility shift assay (29, 51) . We found that rhRPA-•32∆1-33 had wild-type DNA-binding activity; titrations of rhRPA•32∆1-33 and wild-type RPA were identical, and the complexes formed by the mutant were indistinguishable from those formed by wild-type RPA (Fig. 1) .
We examined next the ability of the N-terminal deletion mutant to support in vitro SV40 DNA replication. The mutant complex supported DNA replication and the products synthesized in the presence of hRPA•32∆1-33 were indistinguishable from those made with wild-type rhRPA ( Fig. 2A and B, lanes 2 and 6) . Titrations indicated that rhRPA•32∆1-33 had a specific activity ∼50% that of wild-type RPA (Fig. 2A) .
Phosphorylation of rhRPA•32∆1-33
Phosphorylation of mutant RPA complexes under DNA replication conditions. In the cell-free replication system, rhRPA becomes multiply phosphorylated (29, 30) . Hyperphosphorylated hRPA32 can be detected by a decrease in its apparent electrophoretic mobility (Fig. 3A, lanes 4-6) . When rhRPA•32∆1-33 was incubated under replication conditions in presence of ssDNA, no change in mobility was detected, indicating that it was not phosphorylated (Fig. 3A, lanes 7-9) . [The minor band with lower mobility is a contaminant present in the starting fraction of rhRPA•32∆1-33 (Fig. 3A, lane 2) .] In order to determine if rhRPA•32∆1-33 was phosphorylated inefficiently, assay conditions were modified to increase levels of phosphorylation. The CFIBC fraction used to reconstitute SV40 DNA replication has been shown by protein purification (52, 53) and by inhibitor studies (L.A.H. and M.S.W., unpublished) to contain Protein Phosphatase 2A. Omission of CFIBC increased the level of phosphorylation of rhRPA32 (Fig. 3A, lanes 5 and 6) ; however, the 32 kDa subunit of rhRPA•32∆1-33 remained unphosphorylated (Fig. 3A,  lane 9 ). These data indicate that the N-terminus of RPA32 is required for the efficient phosphorylation of rhRPA in vitro.
Phosphorylation by DNA-PK. We also examined the ability of DNA-PK to phosphorylate rhRPA•32∆1-33. Kinase assays were carried out using casein (a known substrate of DNA-PK), wild-type rhRPA or rhRPA•32∆1-33 and the products were separated on a SDS-polyacrylamide gel. A change in the apparent molecular weight of RPA32 was observed with wild-type RPA, indicating that under these conditions purified DNA-PK catalyzed the hyperphosphorylation of rhRPA (Fig. 3B) . Single-stranded M13 strongly stimulated the hyperphosphorylation of rhRPA ( Fig. 3B and C) . RPA undergoes a conformational change upon binding to ssDNA (49) . It seems likely that this conformational change causes RPA to be a better substrate for DNA-PK. The hyperphosphorylation of RPA was not due to ssDNA causing a stimulation of DNA-PK: under the conditions used, we observed a decrease in the phosphorylation of casein in the presence of ssDNA (Fig. 3B and C) . This is consistent with previous studies which have shown that DNA-PK activity is reduced in the presence of ssDNA (31) . In addition, the hyperphosphorylation is probably not due to contaminating kinase activity because under these assay conditions no phosphorylation of RPA or casein was observed in the absence of added stimulatory ds-oligonucleotide or Ku autoantigen and dsDNA (data not shown).
When hRPA•32∆1-33 was incubated with DNA-PK, either in the presence or absence of ssM13, no change in the apparent mobility was observed (Fig. 3B ). An autoradiogram of this gel demonstrated that the slower migrating forms of the 32 kDa subunit of rhRPA were labeled with 32 P (Fig. 3C ) and confirmed that incorporation of 32 P increased in the presence of ssDNA (Fig. 3C) . rhRPA•∆1-33 was not labeled (Fig. 3C) . We conclude that rhRPA•∆1-33 is not phosphorylated by DNA-PK in vitro.
Location of DNA-PK phosphorylation sites on rhRPA. To date, the sites of RPA32 that are phosphorylated have not been identified. Peptide mapping has demonstrated that the p34 cdc2 kinase consensus sites at serines 23 and 29 are phosphorylated in vitro but that there are additional sites of phosphorylation on RPA32 (27) . The failure of rhRPA•32∆1-33 to become hyperphosphorylated under in vitro DNA replication conditions or by direct phosphorylation with DNA-PK may indicate that all the DNA-PK phosphorylation sites on hRPA32 are located at the N-terminus. Alternatively, rhRPA•32∆1-33 may not be phosphorylated due to the loss of specific protein-protein interactions with DNA-PK or a conformational change in rhRPA•32∆1-33 that hinders phosphorylation. To distinguish between these possibilities, we used limited proteolysis to determine which region(s) of RPA32 were phosphorylated by DNA-PK.
We have shown previously that when rhRPA•32∆1-33 or wild-type rhRPA are treated with trypsin, the N-terminus of the 32 kDa subunit is rapidly digested to give a ∼28 kDa polypeptide containing the central and C-terminal regions of RPA32 (49) . If all phosphorylation of RPA32 occurs on residues near the N-terminus, all incorporated 32 P should be removed by this initial cleavage event. To test this hypothesis, wild-type rhRPA phosphorylated with DNA-PK was digested for various times with trypsin and the resulting proteolytic products separated by SDS-polyacrylamide electrophoresis. We found that with phosphorylated rhRPA, trypsin treatment rapidly removed the N-terminus to give a ∼28 kDa polypeptide (Fig. 4, band labeled 32′) . This fragment was then degraded into smaller fragments (Fig. 4A, compare 5 and 30 min) . When incorporated 32 P was detected by autoradiography, we found that the ∼28 kDa proteolysis product contained no 32 P (Fig. 4C) . The loss of label was not due to endogenous phosphatase activity because no loss of label was observed in control experiments in which phosphorylated RPA was incubated with trypsin inhibited with trypsin inhibitor. We conclude that all DNA-PK phosphorylation sites on the 32 kDa subunit of RPA are located in the N-terminal 33 amino acids. 
Effect of DNA-PK phosphorylation on DNA replication
Previous studies have shown that phosphorylation of RPA by DNA-PK is not essential for replication activity (31, 46) ; however, it is not known whether phosphorylation by DNA-PK can modulate DNA replication. In order to examine this possibility, we tested the effect of DNA-PK on SV40 replication in the presence of either rhRPA or rhRPA•32∆1-33. DNA-PK requires the presence of dsDNA for activity; therefore, a ds-oligonucleotide was added with DNA-PK. Addition of oligonucleotide alone caused a slight diminution of DNA synthesis in the presence of either rhRPA or rhRPA•32∆1-33 (data not shown). When rhRPA was incubated with DNA-PK and the mixture was added to a replication reaction, the level of DNA replication was similar to the dsDNA control (Fig. 2B, lanes 2 and  3) . However, when rhRPA•32∆1-33 was preincubated with DNA-PK, replication was strongly inhibited (Fig. 2B, lanes 6 and  7) . This inhibition was not caused by a general inhibition of replication proteins because it did not occur with wild-type RPA. Adding rhRPA partially restores DNA synthesis indicating that the inhibition was not irreversible (Fig. 2B, lane 8) . Similar results were obtained in reactions containing DNA-PK, Ku and dsDNA (data not shown). We conclude that the inhibition observed in reactions containing rhRPA•32∆1-33 must be due to both the presence of DNA-PK and the loss of the N-terminus of RPA32.
DISCUSSION
We constructed an N-terminal truncation of the 32 kDa subunit of hRPA, rhRPA•32∆1-33, to examine the role of phosphorylation of RPA on the regulation of DNA replication. The ssDNA binding activity of this mutant was identical to that of wild-type rhRPA. In addition, rhRPA•32∆1-33 was able to support in vitro SV40 DNA replication, albeit with reduced activity. The lower activity of rhRPA•32∆1-33 seems likely to be a difference in the specific activity of the protein preparations because a similar mutant isolated by Lee and Kim (47) showed no decrease in activity. rhRPA•32∆1-33 was not phosphorylated in vitro either under DNA replication conditions or using purified DNA-PK. This demonstrates that the N-terminus of RPA32 is essential for phosphorylation.
Studies using synthetic peptides have shown that the consensus phosphorylation site for DNA-PK is either a serine or threonine followed by glutamine (33) . There are four serines in this context in RPA32 (S33, S52, S72, S174). Even though rhRPA•32∆1-33 lacks only one of these consensus phosphorylation sites, it was not phosphorylated by DNA-PK. It is possible the N-terminus of the 32 kDa subunit is necessary for substrate recognition by DNA-PK. However, this possibility was ruled out in proteolysis experiments in which all incorporated 32 P was removed when ∼4 kDa was digested from the N-terminus from RPA32 (Fig. 4) . This demonstrates that all phosphorylation of RPA by DNA-PK occurs on the N-terminal 33 amino acids of RPA32. This region contains eight serines and one threonine. Further, analysis will be required to determine precisely which of these residues are phosphorylated by DNA-PK. These results are consistent with previous finding that DNA-PK can phosphorylate proteins at non-consensus serines such as the C-terminal domain of RNA polymerase II (33) .
The ability of each rhRPA mutant to support DNA replication clearly demonstrates that phosphorylation of hRPA is not required for in vitro DNA replication. However, when rhRPA•32∆1-33 was pretreated with DNA-PK and the mixture added to a replication reaction, DNA synthesis was strongly inhibited. This inhibition was not observed with wild-type RPA and could be partially reversed by the addition of unphosphorylated RPA. Since rhRPA•32∆1-33 is functional in SV40 replication but does not become phosphorylated, it is likely that the inhibitory effect of DNA-PK is mediated through other proteins in addition to RPA. These results suggest that the N-terminus of RPA32 and, thus possibly phosphorylation of RPA, is important for preventing a negative effect of DNA-PK. This negative effect could be a direct result of rhRPA•32∆1-33 interacting with DNA-PK and causing a change in activity or affecting substrate specificity. Alternatively, the observed results could be caused by an indirect process; rhRPA•32∆1-33 may not be able to interact properly with the phosphorylated form of another protein. One likely candidate for the other regulated protein is SV40 T antigen which is known to be regulated by phosphorylation (33, 54) . Additional studies are needed to determined the mechanism of inhibition of SV40 DNA replication by DNA-PK and the role of RPA in modulating this process.
Besides DNA replication, phosphorylation of RPA by DNA-PK may effect RPA activity in DNA repair and/or recombination. In vivo, the level of phosphorylation of hRPA is increased after DNA damage (25, 26) . The dsDNA ends present after DNA damage or during recombination may be bound by DNA-PK/Ku thereby activating DNA-PK (33). DNA-PK may then phosphorylate proteins involved in the initiation of DNA repair and recombination, such as RPA. RPA directly interacts with the excision repair proteins XPA, XPG and XPF/ERCC1 and is involved in the recognition of DNA damage (18, 19, (55) (56) (57) suggesting that RPA and DNA-PK may co-localize in the regions of DNA damage promoting phosphorylation of RPA. The inhibitory effect of DNA-PK could serve as a checkpoint in DNA repair, preventing the repair from occurring unless RPA is also present.
